Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy
Recruiting
Phase 2
Interventional Study
Esophagogastroduodenoscopy
Simethicone
N-Acetylcysteine
Premedication
Visualization
Esophagogastroduodensocopy (EGD) Procedure
Placebo - Control
Gastritis Associated With Helicobacter Pylori
Tumor Gastric
Lesions in the Esophagus, Stomach, Duodenum or Rectum
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 132 (estimated)
- Sponsor
- Hospital General de Mexicali · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this randomized, double-blind, placebo-controlled clinical trial is to assess whether the combination of N-acetylcysteine and simethicone improves mucosal visibility during upper gastrointestinal endoscopy in adults aged 18 to 99 years of both sexes, including both healthy individuals and those with non-bleeding gastrointestinal symptoms.
The main questions this study aims to answer a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women aged 18 to 70 years old.
* Patients who agree to participate in the clinical trial.
* Patients without active gastrointestinal bleeding.
* Signing of informed consent form.
Exclusion Criteria:
* Patients with a history of hypersensitivity to N-acetylcysteine
* …
Contacts
Jesus Alberto Camacho Escobedo, Gastroenterologist
+ 52 6862146050
CONTACT